Short seller extremely manipulative “research” likely behind much of route today. Cintron “research” out with a short selling piece today highly critical of cytodyn. He is correc that the nearly constant press releases and interviews are excessive, as well as many claims premature and too forward looking. His article is here:
https://citronresearch.com/wp-content/uploads...Scheme.pdf

However, he completely dismisses the science, stating inappropriately that there is no evidence. The evidence (nature of cytokine storms, position of CCR5 and leronlimab to impact cancers and Covid) are the only reason I am here.

The evidence he cites is from Culper, another one man shop short selling “researcher”.

Culper piece: https://img1.wsimg.com/blobby/go/cc91fda7-466...1103388830

Decent article here debunking Culper (references a short attack early in the year pre-Covid)

https://emerginggrowth.com/the-great-cytodyn-...o-impress/.

I have not doubt that Cytodyn could have been more sophisticated with less self promotion these last months. Nonetheless, the science is clear that this drug is a generational find.

The short term is painful and wildly unpredictable. Tune it out. Check back in a month.